Smiths Group PLC
26 September 2007
Smiths Detection selected for Joint Chemical Agent Detector (JCAD) Increment 2
evaluation
US Department of Defense (DoD) will test two different detector configurations
of Smiths Detection's advanced chemical detectors
SMITHS Detection, part of the global technology business Smiths Group, today
announced its military unit has been selected to participate in the first major
phase of Increment 2 of the Joint Chemical Agent Detector (JCAD) Program.
Earlier this year, Smiths Detection was awarded an initial $3.9 million
firm-fixed price contract to supply M4 JCADs to Increment 1 of the JCAD Program.
The M4 JCAD is an advanced, non-radioactive chemical point detector that is
designed to help save the lives of troops by automatically detecting,
identifying and quantifying both chemical warfare agents and toxic industrial
chemicals.
The second increment of the JCAD program builds upon Increment 1 requirements
emphasizing detector sensitivity, false alarm rejection, and networking
capabilities. The DoD will evaluate multiple detectors over the next year.
Smiths Detection has developed two different detector configurations to meet the
requirements for the second increment of the JCAD program. These further enhance
the Smiths Detection product and technology that was chosen for Increment 1 of
the program and is now in production.
Initially ten detectors - five of each configuration - will be procured by the
DoD for evaluation. If successful through multiple evaluation phases, the
long-term potential for the JCAD Increment 2 program is for production of up to
120,000 units for the detector selected.
Stephen Phipson, Group Managing Director of Smiths Detection, said: 'This is the
next phase in helping the DoD to equip the US Military and another important
milestone for our military business.
'Smiths Detection has produced chemical detectors for military forces around the
world for over 40 years and securing the Increment 1 contract of the JCAD
program was a significant win. For both the Department of Defense and Smiths
Detection, it marked the start of one of the most important chemical agent
detection equipment programs ever undertaken.
'The selection of Smiths Detection detectors to the JCAD Increment 2 evaluation
further highlights our commitment to continuous development of technology to
protect US military forces.'
ENDS
About Smiths Detection
Smiths Detection is part of the global technology business Smiths Group. It
offers advanced integrated security solutions for customers in civil and
military markets worldwide and is a leading technology developer and
manufacturer of sensors that detect and identify explosives, chemical and
biological agents, weapons, and contraband. Its advanced technology security
solutions also include Smiths Heimann X-ray imaging systems, millimeter-wave
technology and a specialist software supply business for the management of large
sensor and video surveillance networks. Separate business units focus on
related products for the life sciences, and food manufacturing industries. For
more information visit www.smithsdetection.com
Smiths Group
Smiths is a global technology company listed on the London Stock Exchange. A
world leader in the practical application of advanced technologies, Smiths Group
delivers products and services for the threat & contraband detection, medical
devices, energy and communications markets worldwide. Our products and services
make the world safer, healthier and more productive. Smiths Group employs more
than 20,000 people in over 50 countries. For more information visit
www.smiths.com
Investor Relations Media
Russell Plumley Chris Fox
+44 (0)20 8457 8203 +44 (0)20 8457 8403
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.